openPR Logo
Press release

Fungal Infections Market - Set for Higher Growth by 2025

03-09-2018 05:10 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

Fungal Infections Market - Set for Higher Growth by 2025

Global Fungal Infections Market: Snapshot

Until recently, the occurrence of serious fungal infections had been fairly uncommon. However, with a rapid increase in systemic infections, the global market for fungal infections is slated for tremendous progress over the next few years. One of the primary reasons for the increased incidence of fungal infections is the high acceptance of broad-spectrum antibiotic drugs that decrease or eliminate the nonpathogenic bacteria which compete with fungi. The reduced immune responses of an increasing number of individuals who are affected by cancer chemotherapy agents or acquired immunodeficiency syndrome have also been responsible for the growth of the market for fungal infections.

Elderly people, pregnant women, burn wound victims, and diabetics are more vulnerable to fungal infections. As the worldwide geriatric population has been expanding, the demand for fungal infection treatments is likely to augment. Treatments for fungal infections can either be systemic or topical. Over the next decade, the rising number of product launches will open up new windows of opportunities for the further advancement of the global fungal infection market. The growing number of approvals received by new antifungal products and treatments by regulatory agencies such as the Food and Drug Administration (FDA) is fueling the market as well.

By region, the global fungal infection market can be segmented into Latin America, Asia Pacific, the Middle East and Africa, Europe, and North America. North America is expected to hold the largest share in the global fungal infection market in the forthcoming period. The growing infrastructural facilities and expanding spending capacities of people in the emerging markets of Latin America, Asia Pacific, and Africa will propel the demand for fungal infection products and treatments in these regions.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=497

Global Fungal Infections Market: Overview

Fungi, which includes yeasts, molds, and mildews are some of the common parasites that infect different parts of the human body. Lungs, genitals, skin, digestive tract, liver, and other tissues are commonly affected by fungal infections.

There are some rare types of fungal infections such as fungal keratitis, mucormycosis, and hisptoplasmosis for which treatment is not available. This has led many market players to conduct research activities for the development of drugs for the treatment of these fungal infections. For instance, IASO Pharma Inc. has developed a drug PB-200a for the treatment of aspergillos infection.

Global Fungal Infections Market: Market Segmentation

The global fungal infections market is segmented based on the basis of fungal infections, namely Aspergillos, Candidiasis, C.neoformans cryptoccosis, Dermatophytes, Histoplasmosis, Sporotrichosis, Blastomycosis, Coccidiomycosis, C.gatti cryptococcosis, Fungal Keratitis, Mucormycosis, and Sporotrichosis.

Global Fungal Infection Market: Condition Overview

Pneumocystis pneumonia is the most severe and commonly occurring fungal infection caused by the fungus Pneumocystis jirovecii. It is mostly prevalent in individuals with weakened immune systems such as those suffering from AIDS. Dermatophytes and Candidiasis are other two types of commonly occurring fungal infections. Candidiasis mostly affects soft moist area or skin around the nails in the human body. For instance, vaginal yeast infection in women and diaper rash in babies occur due to candidiasis.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=497

Dermatophytes cause hair, skin, and hair infections. These infections are also known as ringworm or tinea. Some other fungal infections are not common all over the world but are prevalent in specific regions such as blastomycosis in U.S. and Canada and coccidomycosis in Mexico, southwest U.S., and Central and South America.

Global Fungal Infection Market: Market Segmentation

The fungal infections market is divided on the basis of diagnosis into laboratory test, biopsy, and medical imaging. Laboratory testing comprises microscopic examination and blood tests of fungal culture. Fungal culture is the most is one of the most common diagnostic techniques used for detecting fungal infections, while blood test is commonly used to diagnose blastomycosis and coccidomycosis infections.

Medical imaging, which includes CT scans and X-rays is usually performed to detect pnueumocystis pneumonia. Biopsy involves extracting a small part of the infected tissue and is examined under the microscope for the presence of specific fungus. Biopsy is usually performed for the diagnosis of aspergillos, pneumocytosis pneumonia, and sporotrichosis.

On the basis of treatment, the global fungal infections market is divided into antifungal creams and shampoos, antifungal injections, and antifungal oral medicines. Antifungal creams are mainly used for the treatment of fungal infection of the skin and vagina. Some of the commonly used antifungal creams are econazole, ketoconazole, terbinafine, nystatin, amorolfine, clotrimazole, miconazole, tioconazole, and griseofulvin. In case of few fungal infections, which leads to secondary condition such as rashes, antifungal creams are mixed with steroid hydrocortisone for treatment. Antifungal shampoos containing ketoconazole are utilized for treating scalp fungal infection such as dermatophytes.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/fungal-infections-market

Some of the oral medications used for fungal infections are micanazole, terbinafine, Itraconazole, posaconazole, nystatin, fluconazole, griseofulvin, and voriconazole. Antifungal injections are mostly used for treating severe cases of fungal infection.

Major Companies Mentioned in the Report

The report outlines the vendor landscape of the global fungal infections market, which includes a detailed competitive profile of leading companies in this market. Some of the leading companies are Eli Lily and Company, Samyang Corporation, Eisai Co. Ltd., AstraZeneca PLC, and Helix Biomedic Inc.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fungal Infections Market - Set for Higher Growth by 2025 here

News-ID: 970738 • Views: 260

More Releases from TMR Research

Retinitis Pigmentosa (RP) Market Estimated to Experience a Hike in Growth by 202 …
Global Retinitis Pigmentosa (RP) Market: Snapshot Retinitis pigmentosa, is a condition where patients typically loses ability to see at night in young years, side vision in middle age, and focal vision in later in his/her life due to relentless loss of cone photoreceptor cells. Proportions of retinal capacity, for example, the electroretinogram, demonstrate that photoreceptor capacity is decreased normally quite before symptomic night visual impairment, visual-field scotomas, or diminished visual sharpness
Cardiogenic Shock Market Projected to Gain Significant Value by 2025
Global Cardiogenic Shock Market: Snapshot The global cardiogenic shock market is driven by the rising prevalence of cardiac conditions across the world. The steadily growing influence of a sedentary lifestyle and the rising disposable income of customers have driven the demand for junk food. In urban centers across the world, fast food and junk food has become a part of the culture and demand for it is likely to increase consistently
Viral Disease Diagnosis Market 2025 Cepheid, Roche Diagnostics, Thermo Fischer S …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Radiology Information Systems Market to Register Steady Growth During 2025
Global Radiology Information Systems Market: Snapshot A radiology information system (RIS) refers to a networked software system for managing medical images and related data. Some of the major functions of RIS include patient scheduling, tracking radiology orders, examination interpretation, billing information, and results distribution. RIS is used in conjunction with hospital information systems (HIS) and picture archiving and communication system (PACS) to manage image archives and for efficient workflow of radiology

All 5 Releases


More Releases for Fungal

Anti-fungal Drugs Market Size, Share, Trends, Outlook, 2026
As the name suggests, anti-fungal drugs are used to treat fungal infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Fungal infection is usually associated with a weak immune system, with people suffering from HIV and
Anti-microbial/Anti-fungal Tests Market
Microbial and fungal infections are a major cause of death globally and can even cause potential epidemics, creating a huge economic burden on countries, especially developing ones. To nip the spread of such infections in the bud, prevention is a far better solution than cure - accomplished by isolating infected cases and carrying out primary screening tests. Future Market Insights in its report titled ‘Anti-microbial/Anti-fungal Tests Market: Global Industry Analysis
Fungal Infections Market Estimated to Flourish by Forecast 2017 - 2025
Global Fungal Infections Market: Snapshot Until recently, the occurrence of serious fungal infections had been fairly uncommon. However, with a rapid increase in systemic infections, the global market for fungal infections is slated for tremendous progress over the next few years. One of the primary reasons for the increased incidence of fungal infections is the high acceptance of broad-spectrum antibiotic drugs that decrease or eliminate the nonpathogenic bacteria which compete with
Fungal Infections Market - Industry Segmentation & Forecast 2017 - 2025
Global Fungal Infections Market: Snapshot Until recently, the occurrence of serious fungal infections had been fairly uncommon. However, with a rapid increase in systemic infections, the global market for fungal infections is slated for tremendous progress over the next few years. One of the primary reasons for the increased incidence of fungal infections is the high acceptance of broad-spectrum antibiotic drugs that decrease or eliminate the nonpathogenic bacteria which compete with
Fungal Infections Market : Key Growth Factors and Industry Analysis 2025
Global Fungal Infections Market: Snapshot Until recently, the occurrence of serious fungal infections had been fairly uncommon. However, with a rapid increase in systemic infections, the global market for fungal infections is slated for tremendous progress over the next few years. One of the primary reasons for the increased incidence of fungal infections is the high acceptance of broad-spectrum antibiotic drugs that decrease or eliminate the nonpathogenic bacteria which compete with
Fungal Infections Market : Research Report 2017 - 2025
Global Fungal Infections Market: Overview Fungi, which includes yeasts, molds, and mildews are some of the common parasites that infect different parts of the human body. Lungs, genitals, skin, digestive tract, liver, and other tissues are commonly affected by fungal infections. There are some rare types of fungal infections such as fungal keratitis, mucormycosis, and hisptoplasmosis for which treatment is not available. This has led many market players to conduct